Arthritis Drug Reverses Treatment-Resistant Depression
Summary: A pilot randomized controlled clinical trial provides the first targeted clinical evidence that immunotherapy may offer a new treatment avenue for people with treatment-resistant depression. The study tested whether tocilizumab, an anti-inflammatory drug used for autoimmune conditions such as rheumatoid arthritis, can reduce depressive symptoms by blocking the interleukin‑6 (IL‑6) inflammatory pathway. Researchers screened … Read more